Researchers develop new tools to optimize CHO cell lines for making biologic drugs

Chinese hamster ovary (CHO) cells are the most commonly used cells to produce biologics—protein-based drugs for treating cancers, autoimmune diseases and much more. CHO cells are the workhorses behind more than half of the top-selling biologics on the market today, including Humira, Avastin and Rituxan, to name a few.